10-Q: CareView Communications Q3 2026: Persistent Losses Raise Going Concern Doubts

CareView Communications Inc. reported its Q3 2026 results, showing increased revenues but also widening net losses and a significant working capital deficit, leading to substantial doubt about its ability to continue as a going concern.

Summary

• CareView Communications Inc. filed its Q3 2026 report, detailing financial performance for the period ending September 30, 2026.
• Total revenues for the nine months ended September 30, 2026, increased to $7.215 million from $6.683 million in the prior year period.
• However, the company reported a net loss of $2.060 million for the nine months ended September 30, 2026, compared to a net loss of $2.424 million in the same period of 2025.
• The company has a working capital deficit of $45.121 million as of September 30, 2026.
• Management has concluded that without additional funding, the company will not have sufficient funds to meet its obligations within one year, raising substantial doubt about its ability to continue as a going concern.
• The company's stock options and warrants are considered anti-dilutive due to the reported net loss.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the company's continued net losses, working capital deficit, and the explicit statement of substantial doubt about its ability to continue as a going concern without additional funding.

Positives

• Revenue increased by approximately $112,000 for the three months ended September 30, 2026, compared to the same period in 2025, driven by new customer hardware sales.
• Revenue increased by approximately $532,000 for the nine months ended September 30, 2026, compared to the same period in 2025, also driven by new customer hardware sales.
• Operating income for the nine months ended September 30, 2026, was $309,031, an improvement from an operating loss of $68,406 in the same period of 2025.
• The company has a portfolio of 40 patents, indicating investment in intellectual property.
• The sales-based contract model is noted to have an immediate impact on the company's operations, resulting in greater cash flow within 60 days upon shipment of equipment.

Negatives

• The company reported a net loss of $1,020,361 for the three months ended September 30, 2026, an increase of 11.6% from the $914,214 net loss in the third quarter of 2025.
• The net loss for the nine months ended September 30, 2026, was $2,060,224, despite a decrease of 15% from the $2,423,724 net loss in the same period of 2025.
• As of September 30, 2026, the company had a working capital deficit of $45,121,305.
• The company's accumulated deficit was $217,846,775 as of September 30, 2026.
• Management has concluded that without additional funding, the company will not have sufficient funds to meet its obligations within one year from the issuance date of the financial statements, raising substantial doubt about its ability to continue as a going concern.
• There was a material weakness in internal control over financial reporting related to technical accounting matters, leading to disclosure controls and procedures being not effective.
• Interest expense for the nine months ended September 30, 2026, was $2,406,375, remaining unchanged from the prior year period.

Risks

• The company's net losses and working capital deficit raise substantial doubt about its ability to continue as a going concern.
• Without additional funding, the company will not have sufficient funds to meet its obligations within one year from the issuance date of the financial statements.
• The company is subject to risks common to healthcare technology companies, including dependence on key individuals, uncertainty of product development, generation of revenues, positive cash flow, dependence on outside sources of capital, risks associated with research, development, and successful testing of its products, successful protection of intellectual property, ability to maintain and grow its customer base, and susceptibility to infringement on the proprietary rights of others.
• A material weakness in internal control over financial reporting related to technical accounting matters has been identified.
• The company's ability to attain profitable operations is dependent on future events, including obtaining adequate financing and generating sufficient revenue to support its cost structure.

Future Outlook

The company's future outlook is heavily dependent on its ability to secure additional funding and achieve profitable operations. Management is pursuing increased sales volumes and raising capital through debt or equity securities, but success is not assured. The company's ability to continue as a going concern is in doubt without such funding.

Management Comments

• Management has evaluated the significance of the conditions described above in relation to the Companys ability to meet its obligations and concluded that, without additional funding, the Company will not have sufficient funds to meet its obligations within one year from the date the Condensed Consolidated Financial Statements were issued.
• While management will look to continue funding operations by increased sales volumes and raising additional capital from sources such as sales of its debt or equity securities or loans to meet operating cash requirements, there is no assurance that managements plans will be successful.
• Management continues to monitor the immediate and future cash flows needs of the company in a variety of ways which include forecasted net cash flows from operations, capital expenditure control, new inventory orders, debt modifications, increases in sales outreach, streamlining and controlling general and administrative costs, competitive industry pricing, sale of equities, debt conversions, new product or services offerings, and new business partnerships.

Industry Context

StockSavvy.ai notes that CareView Communications operates in the patient safety and remote monitoring technology sector within healthcare. The increasing demand for remote patient monitoring, driven by staffing shortages and the need for enhanced care, presents an opportunity. However, the company's financial struggles, including persistent losses and a going concern warning, highlight the challenges of scaling in this competitive and capital-intensive industry.

Comparison to Industry Standards

• The filing does not provide specific comparisons to industry standards or competitors' financial results.
• The company's reported net loss and working capital deficit are significant concerns when compared to established, profitable companies in the healthcare technology sector.

Legal Proceedings

• None.

Related Party Transactions

• Notes payable - related parties of $700,000 are listed on the balance sheet.

Stakeholder Impact

• Shareholders: The company's financial instability and going concern warning pose significant risks to shareholder value.
• Creditors: The substantial debt and working capital deficit raise concerns about the company's ability to meet its debt obligations.
• Employees: The uncertainty surrounding the company's future could impact job security.
• Management: Faces significant challenges in securing funding and improving financial performance.

Next Steps

• Management will continue to monitor cash flow needs and pursue increased sales volumes and additional capital.
• The company will continue to implement its remediation plan to address the material weakness in internal controls.
• The company will continue to operate under the assumption that it will continue as a going concern, contingent on successful funding and operational improvements.

Key Dates

Recommendation

The filing indicates significant financial distress, including persistent net losses, a substantial working capital deficit, and a stated doubt about the company's ability to continue as a going concern without additional funding. These factors, combined with a material weakness in internal controls, present a high level of risk for investors.

Keywords

patient safety, video monitoring, healthcare technology, revenue, net loss, going concern, working capital, financial statements